Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
3.550
-0.130 (-3.53%)
At close: Mar 6, 2026, 4:00 PM EST
3.550
0.00 (0.00%)
After-hours: Mar 6, 2026, 4:10 PM EST
MRVI Revenue
In the year 2025, Maravai LifeSciences Holdings had annual revenue of $185.74M, down -28.34%. Maravai LifeSciences Holdings had revenue of $49.87M in the quarter ending December 31, 2025, a decrease of -11.83%.
Revenue (ttm)
$185.74M
Revenue Growth
-28.34%
P/S Ratio
4.94
Revenue / Employee
$337,715
Employees
550
Market Cap
912.59M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 185.74M | -73.44M | -28.34% |
| Dec 31, 2024 | 259.19M | -29.76M | -10.30% |
| Dec 31, 2023 | 288.95M | -594.06M | -67.28% |
| Dec 31, 2022 | 883.00M | 83.76M | 10.48% |
| Dec 31, 2021 | 799.24M | 515.14M | 181.33% |
| Dec 31, 2020 | 284.10M | 140.96M | 98.48% |
| Dec 31, 2019 | 143.14M | 19.31M | 15.59% |
| Dec 31, 2018 | 123.83M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Fortrea Holdings | 2.72B |
| MannKind | 348.97M |
| Geron | 183.88M |
| UroGen Pharma | 109.79M |
| Arbutus Biopharma | 14.61M |
| Compass Therapeutics | 850.00K |
MRVI News
- 8 days ago - Maravai LifeSciences Holdings, Inc. (MRVI) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Maravai Lifesciences Reports Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 25 days ago - Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026 - Business Wire
- 4 months ago - Maravai LifeSciences Announces November 2025 Investor Conference Schedule - Business Wire
- 4 months ago - Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Maravai LifeSciences Reports Third Quarter 2025 Financial Results - Business Wire
- 4 months ago - MARAVAI INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Continues Investigation on Behalf of Maravai Long-Term Stockholders - GlobeNewsWire
- 4 months ago - Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 6, 2025 - Business Wire